Skip to main content

West Pharmaceutical Services statistics

  • WST · NYSE
  • Medical devices
  • Health Care Supplies
  • S&P 500
$416.42+1.24%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$28.91B
EV / EBITDA29.97
EV / sales8.51

Share price

Latest close$416.42
Day's change+1.2%
52-week high$438.27
52-week low$223.83
From 52-week high−5.0%
Return · 1 month+8.4%
Return · 3 months+17.7%
Return · year to date+51.3%
Return · 1 year+52.1%
Beta · 1 year against the S&P 5000.65
50-day average$380.18
200-day average$321.39
RSI 1465.8
Average volume · 20 sessions764K

Margins and returns

For fiscal 2025, as filed.

Gross margin35.9%
Operating margin19.0%
Net margin16.1%
Free cash flow margin15.3%
Return on equity16.9%
Return on assets11.8%
Return on invested capital16.7%
Return on capital employed17.4%
Stock-based compensation / revenue0.8%

Financial position

At the end of fiscal 2025.

Cash and equivalents$791.3M
Total debt$321.1M
Net debt−$470.2M
Current ratio3.02
Debt / equity0.10
Net debt / EBITDA−0.62
Interest coverage1169.80

Shares and dividends

For fiscal 2025, as filed.

Diluted shares72.7M
Net share repurchases$122.7M
Dividends per share$0.86
Dividend payout12.4%

Taxes

For fiscal 2025, as filed.

Income tax expense$121.6M
Effective tax rate20.2%

WST in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.